For Eye Care Professionals
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting
Bausch + Lomb Corporation Announces Launch of IPO and Roadshow
Bausch Health Enters Into Arrangement Agreement With Bausch + Lomb Corporation In Connection With Previously Announced Proposed Separation
Bausch + Lomb will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment Nov03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
Bausch + Lomb Will Present New Scientific Data During The American Society Of Cataract And Refractive Surgery Annual Meeting
Bausch + Lomb And Clearside Biomedical Announce The U.S. Commercial Launch Of Xipere® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use For The Treatment Of Macular Edema Associated With Uveitis
Bausch + Lomb and Prevent Blindness Launch Annual AMD Awareness Month Campaign to Educate Patients
Dr. Yehia Hashad will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer
New Survey from Bausch + Lomb and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients
Bausch + Lomb Reports More Than 41 Million Units of Contact Lens, Eye and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
Bausch + Lomb Will Present Scientific Data and Analyses during the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings
Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration with TerraCycle in the United States
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (Triamcinolone Acetonide Injectable Suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial of NOV03 (Perfluorohexyloctane) in Dry Eye Disease Associated With Meibomian Gland Dysfunction
Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving its Surgical Technologies at the 2021 Annual Meeting of the American Society of Cataract and Refractive Surgery
Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes
Bausch + Lomb Completes Enrollment of Second Phase 3 Study for NOV03 (perfluorohexyloctane)
Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses